Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × toripalimab × Clear all

NCT06548763 2024-08-12

Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Neoplasms